Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.35 |
| ▸ | GRK2 | P25098 | 1/20 | 0.35 |
| ▸ | CDC7 | O00311 | 1/20 | 0.35 |
| ▸ | PLK4 | O00444 | 1/20 | 0.35 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.35 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12092546 | 0.84 | NOTUM (0.44) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL12833872 | 0.81 | NOTUM (0.41) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31124025 | 0.73 | NOTUM (0.71) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31434746 | 0.73 | NOTUM (0.49) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL31123893 | 0.73 | NOTUM (0.47) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL12088789 | 0.71 | HTT (0.60) | RAB9ASMN1; SMN2S1PR1MAPK1MAPT | |
| SCHEMBL20031353 | 0.70 | NOTUM (0.62) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL15686705 | 0.69 | S1PR1 (0.42) | TDP1L3MBTL1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL12088917 | 0.68 | ADRA2B (0.42) | SMN1; SMN2ALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL11786351 | 0.67 | CYP1A2 (0.51) | RAB9ASMN1; SMN2ALDH1A1S1PR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120225886-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME, CORP. (US) | 2012-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225886-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | ADRB3, ADRB1, ADRB2 | TDP1 2895/4885L3MBTL1 4267/4885RAB9A 1162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.